Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 73.86 | 35.75 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 87.11 | 45.81 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 89.07 | 40.03 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 88.05 | 30.39 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 98.57 | 50.60 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 60.79 | 12.66 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 144.66 | 38.53 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 82.80 | 32.65 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 100.01 | 27.77 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 19.54 | 10.47 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 61.82 | 18.13 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 42.20 | 13.72 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 107.92 | 43.32 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 108.70 | 41.09 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 75.30 | 26.89 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 80.76 | 23.51 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 75.22 | 21.91 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 77.09 | 34.16 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 77.32 | 18.84 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 39.98 | 13.06 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 21.94 | 5.96 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 144.55 | 49.23 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 151.79 | 47.36 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 162.33 | 55.36 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 102.32 | 18.19 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 97.37 | 20.85 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 100.67 | 18.81 |
Basophils, donor1.CNhs12546.12241-129G9 | 28.72 | 9.05 |
Basophils, donor2.CNhs12563.12242-129H1 | 29.17 | 10.75 |
Basophils, donor3.CNhs12575.12243-129H2 | 26.16 | 5.88 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 136.07 | 60.68 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 81.93 | 21.69 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 80.61 | 12.20 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 88.39 | 19.06 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 224.91 | 46.06 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 71.64 | 21.14 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 19.94 | 6.65 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 22.86 | 6.62 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 19.75 | 8.25 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 53.74 | 18.81 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 57.65 | 23.32 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 43.02 | 15.20 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 16.87 | 6.69 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 27.96 | 23.81 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 17.95 | 9.46 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 17.66 | 4.88 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 27.14 | 12.34 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 19.82 | 4.96 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 17.55 | 6.90 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 22.29 | 6.92 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 25.78 | 4.97 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 18.96 | 9.65 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 32.92 | 10.33 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 8.13 | 8.13 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 15.81 | 5.84 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 22.38 | 11.19 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 22.92 | 5.84 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 15.61 | 5.51 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 29.85 | 9.31 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 22.38 | 3.20 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 18.80 | 3.96 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 24.14 | 11.37 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 19.18 | 3.41 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 13.64 | 3.48 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 23.83 | 7.94 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 15.57 | 2.49 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 20.85 | 5.02 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 27.12 | 6.26 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 27.15 | 5.43 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 14.53 | 5.45 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 37.20 | 8.47 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 21.84 | 6.01 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 42.88 | 10.77 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 41.25 | 9.57 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 42.56 | 11.53 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 27.63 | 6.52 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 32.29 | 6.61 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 29.09 | 5.63 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 35.91 | 7.13 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 46.75 | 7.56 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 44.20 | 7.31 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 61.60 | 33.44 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 58.44 | 28.40 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 67.60 | 34.69 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 60.17 | 40.11 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 76.08 | 39.24 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 67.82 | 35.06 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 59.49 | 27.76 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 55.34 | 34.35 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 64.89 | 22.77 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 56.37 | 15.27 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 55.43 | 20.64 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 54.19 | 17.18 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 39.80 | 13.45 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 63.48 | 18.44 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 34.23 | 12.59 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 35.37 | 11.00 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 33.92 | 11.10 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 50.82 | 18.72 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 31.29 | 15.64 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 31.25 | 10.42 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 25.33 | 13.64 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 154.41 | 120.10 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 38.59 | 9.72 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 36.11 | 14.62 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 34.93 | 7.31 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 65.33 | 38.68 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 101.32 | 77.39 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 77.61 | 44.73 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 109.99 | 79.31 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 100.85 | 48.40 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 27.43 | 12.01 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 28.89 | 8.56 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 32.41 | 11.50 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 119.43 | 76.37 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 34.49 | 13.41 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 31.27 | 11.00 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 38.46 | 13.92 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 35.36 | 23.89 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 30.60 | 26.04 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 34.22 | 23.76 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 35.54 | 23.79 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 39.55 | 26.37 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 44.98 | 21.24 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 32.91 | 20.60 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 43.52 | 19.71 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 26.21 | 15.52 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 32.63 | 10.43 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 30.99 | 12.74 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 36.57 | 26.82 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 101.95 | 29.51 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 138.35 | 32.22 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 144.21 | 37.95 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 80.72 | 36.10 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 79.23 | 37.08 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 89.87 | 23.06 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 54.50 | 16.06 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 150.59 | 46.13 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 143.90 | 60.09 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 132.28 | 52.53 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 37.26 | 20.11 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 36.07 | 9.11 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 48.94 | 11.49 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 33.43 | 20.12 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 31.34 | 19.33 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 36.03 | 23.40 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 62.72 | 30.53 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 82.94 | 41.18 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 69.83 | 26.74 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 82.29 | 21.27 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 92.91 | 30.11 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 83.66 | 23.61 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 65.01 | 23.74 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 62.09 | 28.11 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 96.29 | 33.01 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 81.72 | 21.94 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 71.32 | 27.91 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 90.36 | 33.44 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 78.32 | 24.77 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 109.17 | 27.80 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 106.44 | 28.89 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 58.09 | 16.84 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 112.87 | 24.27 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 77.77 | 18.63 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 134.57 | 43.13 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 101.04 | 31.66 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 102.25 | 29.05 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 75.13 | 23.00 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 70.25 | 22.78 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 113.22 | 49.10 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 9.22 | 3.95 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 11.63 | 0.00 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 39.25 | 9.59 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 84.49 | 48.21 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 100.54 | 36.98 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 52.57 | 20.39 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 40.73 | 11.19 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 99.31 | 34.76 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 97.00 | 29.72 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 83.26 | 11.74 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 57.47 | 22.20 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 93.67 | 32.37 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 111.68 | 39.47 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 134.37 | 45.93 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 74.47 | 24.07 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 100.83 | 28.81 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 32.34 | 6.09 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 142.34 | 36.83 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 110.10 | 24.53 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 152.44 | 39.90 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 215.14 | 57.66 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 222.90 | 61.19 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 242.56 | 67.42 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 108.00 | 40.01 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 156.37 | 39.06 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 81.42 | 33.27 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 93.85 | 8.32 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 77.64 | 20.03 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 32.77 | 14.56 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 12.94 | 3.59 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 198.80 | 42.76 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 169.16 | 39.16 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 122.46 | 47.66 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 103.16 | 27.22 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 92.56 | 35.55 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 78.72 | 20.43 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 145.31 | 58.30 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 57.58 | 15.25 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 118.95 | 27.76 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 130.76 | 30.73 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 55.52 | 15.90 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 122.12 | 32.87 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 63.12 | 16.23 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 111.48 | 30.15 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 54.85 | 10.80 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 119.56 | 35.17 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 66.64 | 16.66 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 114.79 | 30.74 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 99.09 | 29.26 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 50.41 | 17.75 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 136.02 | 36.27 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 136.16 | 30.35 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 191.13 | 110.35 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 149.19 | 101.73 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 148.56 | 81.17 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 176.74 | 39.28 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 181.17 | 42.94 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 184.05 | 43.22 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 147.10 | 33.17 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 151.39 | 39.61 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 229.21 | 56.21 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 62.58 | 12.52 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 79.12 | 19.30 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 73.21 | 13.81 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 113.31 | 39.94 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 114.06 | 63.53 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 133.10 | 43.77 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 159.82 | 43.66 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 164.13 | 42.42 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 127.83 | 46.99 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 159.49 | 46.63 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 161.58 | 39.15 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 153.30 | 52.85 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 170.71 | 51.80 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 171.98 | 45.40 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 69.39 | 17.72 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 14.02 | 4.21 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 36.63 | 16.87 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 44.10 | 5.88 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 111.54 | 30.42 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 105.16 | 14.74 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 101.62 | 32.49 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 94.91 | 32.67 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 79.82 | 42.55 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 152.18 | 45.47 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 196.12 | 106.13 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 136.01 | 34.84 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 300.18 | 107.47 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 172.40 | 35.46 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 37.14 | 2.61 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 45.76 | 9.36 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 223.71 | 36.08 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 151.64 | 40.58 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 114.71 | 52.72 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 83.01 | 22.38 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 83.34 | 23.15 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 77.43 | 24.73 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 85.34 | 24.50 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 71.25 | 29.19 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 60.57 | 17.73 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 55.46 | 31.36 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 61.38 | 21.11 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 179.97 | 115.29 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 150.18 | 64.67 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 182.32 | 97.12 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 140.70 | 46.57 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 222.92 | 39.24 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 122.68 | 39.87 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 107.89 | 50.74 |
Mast cell, donor1.CNhs12566.11563-120D6 | 95.36 | 38.21 |
Mast cell, donor2.CNhs12594.11565-120D8 | 43.54 | 11.40 |
Mast cell, donor3.CNhs12593.11566-120D9 | 39.06 | 6.34 |
Mast cell, donor4.CNhs12592.11567-120E1 | 32.32 | 7.83 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 125.41 | 52.32 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 78.69 | 17.19 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 46.89 | 16.41 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 61.59 | 18.82 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 142.42 | 46.89 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 109.63 | 50.46 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 83.18 | 41.16 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 105.85 | 23.44 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 104.19 | 34.88 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 218.03 | 48.92 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 78.21 | 35.03 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 21.46 | 7.15 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 176.67 | 30.43 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 97.07 | 31.38 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 108.17 | 30.16 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 66.10 | 23.15 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 93.62 | 22.70 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 49.82 | 18.65 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 149.41 | 43.47 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 26.05 | 11.40 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 42.81 | 14.82 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 174.27 | 39.41 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 139.31 | 36.61 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 173.44 | 42.77 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 89.83 | 34.36 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 93.25 | 47.93 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 74.28 | 38.79 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 69.33 | 21.89 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 74.33 | 18.58 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 61.14 | 14.76 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 120.53 | 40.02 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 90.74 | 34.46 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 88.43 | 37.09 |
Myoblast, donor1.CNhs10870.11241-116D8 | 109.31 | 63.27 |
Myoblast, donor2.CNhs11965.11322-117D8 | 94.11 | 27.12 |
Myoblast, donor3.CNhs11908.11398-118D3 | 88.64 | 29.01 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 115.45 | 20.85 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 29.16 | 13.79 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 32.34 | 10.35 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 28.75 | 12.45 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 106.97 | 41.16 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 70.28 | 32.53 |
Neurons, donor1.CNhs12338.11494-119E9 | 77.33 | 30.93 |
Neurons, donor2.CNhs12726.11574-120E8 | 72.70 | 33.17 |
Neurons, donor3.CNhs13815.11655-122E8 | 87.40 | 45.93 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 5.24 | 0.75 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 5.98 | 0.00 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 3.32 | 0.83 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 99.99 | 34.35 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 89.03 | 46.52 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 123.97 | 39.33 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 96.50 | 28.28 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 100.10 | 29.08 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 87.52 | 31.23 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 111.40 | 31.75 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 89.98 | 28.59 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 63.67 | 31.84 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 64.15 | 39.32 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 129.52 | 29.89 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 92.18 | 27.47 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 130.24 | 33.10 |
Pericytes, donor1.CNhs11317.11491-119E6 | 27.61 | 10.96 |
Pericytes, donor2.CNhs12079.11571-120E5 | 24.02 | 12.35 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 32.46 | 14.27 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 25.45 | 7.55 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 25.51 | 8.32 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 47.59 | 12.13 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 78.22 | 11.65 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 66.83 | 18.45 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 89.32 | 41.68 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 50.03 | 23.48 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 78.87 | 30.87 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 89.31 | 46.64 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 97.22 | 32.75 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 77.37 | 37.80 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 86.08 | 29.68 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 131.70 | 33.62 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 114.70 | 34.80 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 122.62 | 35.15 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 82.04 | 18.69 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 116.21 | 39.40 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 110.59 | 54.02 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 133.14 | 66.97 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 103.41 | 14.73 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 111.94 | 22.04 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 107.98 | 18.76 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 72.91 | 23.60 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 29.78 | 10.38 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 190.54 | 46.83 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 23.53 | 4.71 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 26.31 | 8.77 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 165.82 | 34.41 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 32.98 | 7.96 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 77.90 | 25.00 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 113.79 | 34.55 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 13.88 | 10.80 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 31.97 | 10.30 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 18.06 | 6.52 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 77.23 | 20.14 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 61.50 | 11.64 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 39.63 | 11.19 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 96.69 | 11.62 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 100.91 | 10.98 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 229.01 | 44.11 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 70.52 | 21.65 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 157.48 | 39.70 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 75.74 | 31.02 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 209.24 | 40.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 242.17 | 47.36 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 172.85 | 88.44 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 201.52 | 102.06 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 120.51 | 30.53 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 84.39 | 20.78 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 173.92 | 50.07 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 191.42 | 54.95 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 240.39 | 59.82 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 139.11 | 56.50 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 154.01 | 42.49 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 189.29 | 53.10 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 117.79 | 41.93 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 108.43 | 29.59 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 59.96 | 22.10 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 30.63 | 10.59 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 67.07 | 14.77 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 154.33 | 50.20 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 58.56 | 19.20 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 73.19 | 18.82 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 60.37 | 9.55 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 62.81 | 17.03 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 80.03 | 22.62 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 85.81 | 25.20 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 98.18 | 34.78 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 153.33 | 64.38 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 126.87 | 59.80 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 117.05 | 54.90 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 36.34 | 8.44 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 106.98 | 33.38 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 68.73 | 15.59 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 76.92 | 10.99 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 140.66 | 34.54 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 154.84 | 47.22 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 145.85 | 42.18 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 60.45 | 14.96 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 66.57 | 34.87 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 89.31 | 21.91 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 40.96 | 3.90 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 59.95 | 26.08 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 83.46 | 14.79 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 136.91 | 33.17 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 79.61 | 23.90 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 46.33 | 14.69 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 62.86 | 9.92 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 66.34 | 27.20 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 76.73 | 33.76 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 54.40 | 15.05 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 120.03 | 36.73 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 66.96 | 17.25 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 71.57 | 19.21 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 89.86 | 21.69 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 192.74 | 49.33 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 153.96 | 40.97 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 80.25 | 18.90 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 166.74 | 34.06 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 75.79 | 36.10 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 89.90 | 34.25 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 56.92 | 9.11 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 41.99 | 11.90 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 106.81 | 22.32 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 72.39 | 16.76 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 91.47 | 22.87 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 69.38 | 30.88 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 62.85 | 14.64 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 55.60 | 13.48 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 40.80 | 7.54 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 135.77 | 21.59 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 30.95 | 13.19 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 13.76 | 12.23 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 18.23 | 6.84 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 24.54 | 15.01 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 25.09 | 11.11 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 16.21 | 8.43 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 22.68 | 8.64 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 22.21 | 6.35 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 181.81 | 66.87 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 77.96 | 13.47 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 205.34 | 37.98 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 64.47 | 21.55 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 152.06 | 34.05 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 102.44 | 27.89 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 116.22 | 41.45 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 210.56 | 51.89 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 120.84 | 41.75 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 57.36 | 24.55 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 151.27 | 34.41 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 88.73 | 38.75 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 85.13 | 36.75 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 125.66 | 21.15 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 100.25 | 32.58 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 261.89 | 95.31 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 140.19 | 23.93 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 85.56 | 12.92 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 114.13 | 67.28 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 110.27 | 13.74 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 411.40 | 627.39 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 342.00 | 440.42 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 406.11 | 627.35 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 293.28 | 110.00 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 47.89 | 11.41 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 55.39 | 19.69 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 128.47 | 31.91 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 58.62 | 27.98 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 38.07 | 16.92 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 119.58 | 37.05 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 49.67 | 19.63 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 115.17 | 27.31 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 90.16 | 10.14 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 220.21 | 34.38 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 69.95 | 26.50 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 66.52 | 16.93 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 74.95 | 27.95 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 68.60 | 55.67 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 47.12 | 44.59 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 87.82 | 15.58 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 196.45 | 65.26 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 141.88 | 39.69 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 54.39 | 21.12 |
appendix, adult.CNhs12842.10189-103D9 | 54.70 | 15.75 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 94.98 | 20.66 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 180.61 | 33.65 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 117.79 | 20.43 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 143.39 | 39.50 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 115.57 | 21.21 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 52.81 | 6.98 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 61.90 | 24.56 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 75.46 | 16.77 |
blood, adult, pool1.CNhs11761.10053-101G8 | 31.13 | 19.16 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 110.03 | 31.12 |
brain, adult, donor1.CNhs11796.10084-102B3 | 70.76 | 41.68 |
brain, adult, pool1.CNhs10617.10012-101C3 | 78.02 | 50.28 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 27.95 | 31.94 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 77.87 | 31.51 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 87.46 | 31.84 |
breast, adult, donor1.CNhs11792.10080-102A8 | 53.65 | 41.32 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 83.87 | 21.28 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 148.48 | 42.71 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 67.84 | 14.66 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 200.64 | 23.79 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 361.01 | 56.86 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 127.09 | 21.53 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 72.63 | 42.52 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 53.67 | 60.18 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 54.93 | 27.46 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 41.36 | 20.46 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 67.38 | 33.99 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 77.88 | 46.29 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 148.16 | 35.30 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 131.76 | 31.65 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 71.33 | 20.55 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 127.05 | 43.07 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 55.57 | 11.07 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 177.45 | 49.82 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 169.82 | 88.66 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 103.68 | 48.49 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 92.06 | 30.32 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 152.45 | 86.88 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 118.54 | 19.42 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 186.96 | 80.37 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 150.09 | 49.86 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 212.29 | 24.14 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 203.91 | 24.31 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 203.90 | 28.36 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 328.65 | 61.29 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 176.42 | 46.25 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 183.57 | 47.69 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 138.91 | 38.36 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 173.44 | 103.05 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 189.56 | 29.43 |
colon, adult, donor1.CNhs11794.10082-102B1 | 70.66 | 28.86 |
colon, adult, pool1.CNhs10619.10014-101C5 | 83.50 | 58.82 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 46.44 | 23.83 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 61.97 | 23.43 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 100.33 | 39.17 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 100.14 | 41.87 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 39.36 | 25.28 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 61.00 | 54.58 |
diencephalon, adult.CNhs12610.10193-103E4 | 58.80 | 51.54 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 174.61 | 32.11 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 107.03 | 12.13 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 231.37 | 82.06 |
ductus deferens, adult.CNhs12846.10196-103E7 | 46.17 | 27.23 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 62.92 | 33.88 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 26.93 | 15.92 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 64.58 | 17.82 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 143.41 | 53.82 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 322.37 | 98.71 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 116.31 | 15.95 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 141.66 | 8.61 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 98.26 | 11.62 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 118.28 | 14.34 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 181.30 | 42.98 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 89.58 | 19.14 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 102.57 | 36.45 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 144.05 | 36.36 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 226.53 | 43.88 |
epididymis, adult.CNhs12847.10197-103E8 | 65.17 | 29.00 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 139.31 | 31.47 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 145.13 | 38.12 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 125.42 | 30.41 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 143.70 | 42.37 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 64.21 | 25.99 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 130.53 | 27.01 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 84.97 | 31.41 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 200.77 | 39.61 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 243.23 | 59.02 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 63.50 | 53.56 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 147.45 | 37.15 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 153.50 | 16.27 |
gall bladder, adult.CNhs12848.10198-103E9 | 46.11 | 13.23 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 107.30 | 25.58 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 182.56 | 20.46 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 114.99 | 44.55 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 54.74 | 20.59 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 395.57 | 29.24 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 284.04 | 59.52 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 86.03 | 25.69 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 103.29 | 35.20 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 109.21 | 34.83 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 160.85 | 26.93 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 149.68 | 51.14 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 59.44 | 46.83 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 35.60 | 32.58 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 6.39 | 0.00 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 103.57 | 42.98 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 169.30 | 84.65 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 59.77 | 34.35 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 50.19 | 18.79 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 40.92 | 14.36 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 89.86 | 27.56 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 73.83 | 28.33 |
heart, adult, pool1.CNhs10621.10016-101C7 | 60.48 | 28.57 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 67.12 | 30.10 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 81.07 | 30.27 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 61.74 | 19.80 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 108.25 | 49.71 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 113.40 | 52.17 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 106.97 | 42.94 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 176.87 | 31.20 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 165.45 | 25.66 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 62.03 | 62.03 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 42.50 | 33.91 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 199.33 | 51.44 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 218.69 | 53.64 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 213.12 | 51.10 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 39.60 | 11.70 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 37.14 | 25.54 |
insula, adult, pool1.CNhs10646.10039-101F3 | 59.23 | 45.81 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 168.39 | 38.57 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 62.97 | 24.27 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 43.64 | 19.25 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 208.56 | 77.30 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 77.63 | 21.34 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 115.72 | 22.26 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 88.62 | 64.32 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 131.76 | 61.57 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 143.66 | 32.29 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 99.91 | 26.06 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 89.01 | 17.28 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 111.37 | 31.03 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 112.55 | 46.69 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 124.21 | 70.02 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 82.13 | 25.39 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 118.07 | 33.09 |
liver, adult, pool1.CNhs10624.10018-101C9 | 93.50 | 33.12 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 141.78 | 92.75 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 54.95 | 53.91 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 46.41 | 47.74 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 50.47 | 13.86 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 81.05 | 31.72 |
lung, adult, pool1.CNhs10625.10019-101D1 | 86.60 | 42.93 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 83.48 | 33.17 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 71.66 | 37.28 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 65.00 | 38.70 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 65.41 | 18.77 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 91.34 | 17.90 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 92.56 | 33.83 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 65.83 | 22.85 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 76.71 | 29.33 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 66.78 | 13.79 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 73.44 | 32.13 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 89.52 | 16.49 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 76.20 | 56.71 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 65.04 | 48.32 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 51.20 | 47.95 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 80.28 | 56.19 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 53.02 | 41.93 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 53.96 | 38.44 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 171.69 | 36.80 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 120.23 | 31.12 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 103.58 | 53.38 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 192.69 | 25.41 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 107.52 | 14.35 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 77.28 | 22.01 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 65.50 | 19.71 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 102.39 | 28.81 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 109.61 | 35.99 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 125.94 | 36.06 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 107.01 | 41.86 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 90.06 | 41.51 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 92.54 | 44.49 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 86.27 | 35.47 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 93.91 | 29.64 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 94.51 | 32.64 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 105.86 | 27.94 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 97.33 | 33.93 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 80.51 | 28.79 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 100.30 | 33.07 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 88.75 | 20.32 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 121.49 | 34.56 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 87.65 | 27.13 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 101.87 | 25.84 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 82.25 | 30.08 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 145.25 | 47.60 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 96.02 | 33.10 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 86.68 | 36.30 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 95.59 | 30.16 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 89.97 | 26.27 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 165.21 | 46.40 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 82.41 | 27.82 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 84.52 | 26.94 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 90.85 | 47.95 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 169.70 | 16.76 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 114.30 | 23.37 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 122.93 | 36.80 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 161.41 | 21.08 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 106.73 | 39.59 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 72.69 | 32.55 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 104.41 | 41.19 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 136.49 | 30.88 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 72.14 | 29.60 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 112.73 | 38.69 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 57.30 | 11.77 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 132.11 | 27.71 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 130.94 | 34.08 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 135.06 | 41.80 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 293.83 | 81.43 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 43.41 | 41.20 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 105.81 | 22.41 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 92.34 | 17.27 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 79.00 | 16.85 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 317.13 | 30.14 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 242.09 | 44.73 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 94.67 | 18.17 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 119.19 | 60.60 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 158.33 | 25.71 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 77.15 | 22.56 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 92.51 | 44.83 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 91.50 | 18.04 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 98.48 | 11.89 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 74.65 | 8.09 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 67.14 | 25.71 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 83.56 | 46.90 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 176.14 | 33.18 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 105.82 | 27.52 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 176.18 | 50.75 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 87.16 | 40.60 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 116.38 | 34.70 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 193.85 | 44.69 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 80.14 | 25.44 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 173.10 | 15.06 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 90.46 | 21.62 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 94.16 | 33.15 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 95.55 | 28.48 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 54.59 | 44.64 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 85.02 | 45.34 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 38.79 | 37.51 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 70.97 | 61.53 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 46.13 | 31.51 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 45.57 | 31.19 |
olfactory region, adult.CNhs12611.10195-103E6 | 66.53 | 34.88 |
optic nerve, donor1.CNhs13449.10277-104E7 | 39.98 | 29.98 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 87.74 | 31.21 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 243.61 | 27.84 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 54.11 | 11.56 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 158.85 | 20.68 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 86.19 | 27.84 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 184.33 | 41.42 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 536.08 | 330.40 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 74.98 | 32.11 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 98.84 | 35.90 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 55.49 | 15.63 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 138.55 | 47.93 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 164.43 | 38.16 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 96.70 | 14.64 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 59.70 | 43.56 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 71.86 | 51.55 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 50.02 | 44.23 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 50.61 | 46.17 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 41.02 | 26.25 |
parotid gland, adult.CNhs12849.10199-103F1 | 42.76 | 17.00 |
penis, adult.CNhs12850.10200-103F2 | 65.00 | 28.78 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 133.66 | 21.63 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 89.18 | 16.86 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 65.36 | 25.18 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 88.44 | 20.85 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 31.56 | 13.35 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 26.86 | 10.24 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 46.48 | 19.96 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 214.91 | 41.83 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 130.33 | 52.48 |
pons, adult, pool1.CNhs10640.10033-101E6 | 68.17 | 64.50 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 51.43 | 39.46 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 210.15 | 46.45 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 151.83 | 50.72 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 69.78 | 30.38 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 52.48 | 57.35 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 111.55 | 26.91 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 77.62 | 37.44 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 102.35 | 10.36 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 127.56 | 3.82 |
retina, adult, pool1.CNhs10636.10030-101E3 | 56.39 | 19.23 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 183.30 | 28.13 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 165.30 | 48.24 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 140.48 | 24.51 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 61.73 | 13.63 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 82.47 | 35.64 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 58.90 | 22.71 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 37.33 | 15.21 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 40.44 | 15.49 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 121.29 | 30.17 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 121.00 | 25.39 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 48.27 | 34.29 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 87.98 | 27.49 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 120.98 | 30.40 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 156.71 | 38.22 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 108.61 | 48.99 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 175.10 | 32.39 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 68.88 | 19.02 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 58.92 | 25.90 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 73.20 | 37.88 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 61.47 | 55.67 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 63.14 | 41.77 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 143.87 | 49.13 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 113.60 | 30.04 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 264.36 | 66.48 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 138.02 | 34.56 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 114.56 | 14.62 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 87.26 | 15.85 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 103.49 | 97.47 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 72.78 | 18.58 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 51.26 | 5.64 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 65.21 | 24.76 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 35.82 | 8.48 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 64.19 | 56.93 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 55.25 | 45.15 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 52.83 | 48.61 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 78.51 | 26.00 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 57.52 | 22.37 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 35.58 | 13.92 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 81.75 | 23.69 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 131.95 | 26.60 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 73.40 | 12.35 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 75.83 | 14.92 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 48.93 | 16.80 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 33.95 | 17.89 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 37.55 | 34.11 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 135.21 | 46.07 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 43.85 | 29.85 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 32.73 | 17.02 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 68.24 | 17.46 |
tenocyte, donor1.CNhs12639.11763-123H8 | 83.70 | 24.92 |
tenocyte, donor2.CNhs12640.11765-123I1 | 66.55 | 34.66 |
tenocyte, donor3.CNhs12641.11768-123I4 | 86.09 | 32.45 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 221.80 | 42.01 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 211.32 | 42.61 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 173.32 | 68.04 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 132.48 | 53.24 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 194.00 | 33.13 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 145.38 | 56.61 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 131.37 | 40.11 |
testis, adult, pool1.CNhs10632.10026-101D8 | 37.59 | 20.99 |
testis, adult, pool2.CNhs12998.10096-102C6 | 22.51 | 19.29 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 53.07 | 34.83 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 40.65 | 32.58 |
throat, adult.CNhs12858.10209-103G2 | 60.35 | 31.35 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 55.47 | 35.71 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 40.88 | 12.08 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 31.97 | 13.47 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 161.81 | 34.87 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 68.61 | 26.41 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 55.38 | 25.06 |
tongue, adult.CNhs12853.10203-103F5 | 84.04 | 50.95 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 89.67 | 64.34 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 44.59 | 15.49 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 48.84 | 17.36 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 60.54 | 23.95 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 91.17 | 26.54 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 142.80 | 26.58 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 83.02 | 19.31 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 85.42 | 29.46 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 96.20 | 39.89 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 69.31 | 24.20 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 96.03 | 51.68 |
vagina, adult.CNhs12854.10204-103F6 | 43.27 | 19.97 |
vein, adult.CNhs12844.10191-103E2 | 48.51 | 15.30 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 102.58 | 29.81 |